Table 3.
Controls | RA | AS | PsA | |
---|---|---|---|---|
rs10975519 | ||||
C | 308 (67.2%) | 611 (65.5%) | 179 (62.6%) | 163 (64.7%) |
T | 150 (32.8%) | 321 (34.4%) | 54 (37.4%) | 89 (35.3%) |
CC | 104 (45.4%) | 186 (39.9%) | 54 (37.8%) | 55 (43.7%) |
CT | 100 (43.7%) | 239 (51.3%) | 71 (49.7%) | 53 (42.1%) |
TT | 25 (10.9%) | 41 (8.8%) | 18 (12.6%) | 18 (14.3%) |
rs16924159 | ||||
A | 169 (36.9%) | 358 (38.4%) | 116 (40.6%) | 96 (38.1%) |
G | 289 (63.1%) | 574 (61.6%) | 170 (59.4%) | 156 (61.9%) |
AA | 29 (12.7%) | 65 (13.9%) | 21 (14.7%) | 20 (15.9%) |
AG | 111 (48.5%) | 228 (48.9%) | 74 (51.7%) | 56 (44.4%) |
GG | 89 (38.9%) | 173 (37.1%) | 48 (33.6%) | 50 (39.7%) |
rs7044343 | ||||
C | 174 (38.0%) | 362 (38.8%) | 122 (42.7%) | 101 (40.4%) |
T | 284 (62.0%) | 570 (61.2%) | 164 (57.3%) | 149 (59.6%) |
CC | 31 (13.5%) | 55 (11.8%) | 27 (18.9%) | 21 (16.8%) |
CT | 112 (48.9%) | 252 (54.1%) | 68 (47.6%) | 59 (47.2%) |
TT | 86 (37.6%) | 159 (34.1%) | 48 (33.6%) | 45 (36.0%) |
RA, rheumatoid arthritis; AS, ankylosing spondylitis; PsA, psoriatic arthritis.